Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
Exercise: By reducing insulin sensitivity and aiding in weight control, exercise optimizes the benefits of Mounjaro
Thyroid enlargement, or goiter, is one of the earliest and most visible signs of iodine deficiency
So what does the evidence say
Key Takeaway: Acetaminophen depletion of glutathione is a dose-dependent process
35 were animal studies